The SingHealth Duke-NUS Cell Therapy Centre (SDCT) was established in September 2020 to provide a cluster-wide focal point in coordinating Cell, Tissue and Gene Therapy (CTGT)
education as well as
clinical trials and services.
This integrated and virtual Centre, brings together the strengths and expertise of
healthcare professionals (Clinicians, Allied health professionals and Researchers) from various clinical specialties of SingHealth hospitals and national specialty centres to leverage on advanced CTGT technologies to improve diagnostics, therapeutics, research and health outcomes by providing seamless, high-quality and holistic patient-centric care.
The Centre will also introduce educational programs and conferences for medical professionals focusing on the use of cellular therapies in clinical trials and services; and public forums to promote awareness of CTGT clinical services and provide up to date information for patients and families.
Besides enhancing patient care, SDCT will also focus on formulating and coordinating cluster-wide Research and Development (R&D) activities pertaining to the development of novel CTGT products and associated technologies.
Lastly, the Centre will work with the
Advanced Cell Therapy Research Institute, Singapore (ACTRIS) & Regenerative Medicine Institute of Singapore (REMEDIS) and closely coordinate efforts with other national (for example regulatory authority,
HSA) and international stakeholders to establish Singapore as the hub of CTGT for the region.
Subscribe to our mailing list to get the updates to your inbox